Cargando…
Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum
Autores principales: | Zhao, Yuwan, Luo, Qiuming, Mo, Jierong, Li, Jianwei, Ye, Dongcai, Ao, Zhixian, Chen, Lixin, Liu, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414018/ https://www.ncbi.nlm.nih.gov/pubmed/36046650 http://dx.doi.org/10.7150/jca.76980 |
Ejemplares similares
-
Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks
por: Zhao, Yuwan, et al.
Publicado: (2020) -
Circ-APBB1IP as a Prognostic Biomarker Promotes Clear Cell Renal Cell Carcinoma Progression Through The ERK1/2 Signaling Pathway
por: Mo, Jierong, et al.
Publicado: (2020) -
Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway
por: Zhao, Yuwan, et al.
Publicado: (2019) -
ERRATUM: A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Liu, Bin, et al.
Publicado: (2015) -
Advanced glycation end products promote ChREBP expression and cell proliferation in liver cancer cells by increasing reactive oxygen species: Erratum
Publicado: (2017)